Maia Anderson

1 month ago | healthcare-brew.com | Maia Anderson

Believe it or not, the year is close to halfway over, and it’s been a busy one for pharmaceutical companies, to say the least. So far this year, drugmakers have released two quarters’ worth of earnings, and they’ve covered everything from GLP-1 sales to Medicare Part D changes to tariffs. Here’s a half-time earnings roundup in case you need to catch up. Ups and downsThe only way to describe Q4 2024 earnings, which were reported in January and February, is mixed bag.

1 month ago | healthcare-brew.com | Maia Anderson

Optum Rx is switching up the pharmacy reimbursement game. On March 20, UnitedHealth Group-owned Optum, one of the Big 3 pharmacy benefit managers (PBMs) in the US, announced it would move to a cost-based reimbursement model to “provide pharmacies with better financial means to stock more medicines” and “alleviate drug shortages,” according to a company press release.

1 month ago | healthcare-brew.com | Maia Anderson

Tariffs are the talk of the town. With tariffs placed on China and the threat of more being placed on pharmaceuticals, every corner of healthcare is already affected by the tariffs or likely to be impacted before long. Healthcare Brew compiled what executives across various sectors of the industry have said about tariffs, how they’re influencing healthcare businesses, and how the execs are working to combat any negative consequences.

1 month ago | healthcare-brew.com | Caroline Catherman |Maia Anderson

After 23 years as CEO of New York’s largest health system, Northwell Health, Michael Dowling is moving on—sort of. “I’m stepping down, but I’m not stepping away,” he told Healthcare Brew. On Oct. 1, he’ll be succeeded by John D’Angelo, who’s been with the health system for more than 25 years and currently serves as EVP, market president, and chief of integrated operations.

1 month ago | healthcare-brew.com | Maia Anderson

Medicare may soon be able to reimburse physicians for using artificial intelligence-based medical devices, thanks to a bipartisan bill recently introduced to Congress. The bill, called the Health Tech Investment Act, would set up a payment system for devices that use AI or machine learning, which the bill’s cosponsors say would encourage providers to use the technology in clinical settings and help improve diagnoses.